ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

Clinical Trials Approved By NCI Last Month

March 29, 2002

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984